Astragaloside IV has been shown to quell the spreading of breast cancer via the promotion of lncRNA Thyrotropin Releasing Hormone Degrading Enzyme Antisense RNA 1 (TRHDE-AS1). Here, TRHDE is linked to breast cancer.